Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $112.79 | $24.84 | 354.04% | 212.81x | 53.68x | 14.31x | 17.28x | 1.54x | $106.92M | 0.90% | $705.78M | 6.70 | $12.09B | 1,541.21 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $23.89 | $8.45 | 182.69% | 113.74x | 55.55x | 6.72x | 13.61x | 0.98x | $39.15M | 1.26% | $220.58M | 1.69 | $3.08B | 67.89 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $248.68 | $81.93 | 203.53% | 40.77x | 36.66x | 6.92x | 24.57x | 1.44x | $793.95M | 2.39% | $1.35B | 10.14 | $34.55B | 29.30 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $76.27 | $17.90 | 326.17% | 71.28x | 65.25x | 7.04x | 9.10x | 1.82x | $182.84M | 3.09% | $654.15M | 8.43 | $5.78B | 48.22 | ||
| HALO | HALOZYME THERAPEUTICS INC | $107.20 | $70.16 | 52.80% | 30.11x | 11.87x | 7.56x | 84.76x | 0.62x | $806.22M | 6.41% | $143.54M | 1.22 | $14.15B | 19.69 | ||
| RPRX | ROYALTY PHARMA PLC | $58.61 | $37.21 | 57.51% | 31.18x | 10.94x | 10.29x | 3.44x | 0.63x | $2.92B | 11.21% | $9.79B | 21.99 | $41.85B | 35.59 | ||
| KRYS | KRYSTAL BIOTECH INC | $347.00 | $87.10 | 298.40% | 41.96x | 44.46x | 23.26x | 7.56x | 2.23x | $257.78M | 2.52% | $1.36B | 46.03 | $9.85B | 42.23 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $65.68 | $19.46 | 237.46% | 172.84x | 22.56x | 3.73x | 2.01x | 1.14x | $738.18M | 5.81% | $6.32B | 32.68 | $16.03B | 41.55 | ||
| VCEL | VERICEL CORP | $38.34 | $8.26 | 364.09% | 79.88x | 68.50x | 6.39x | 5.31x | 1.96x | $61.66M | 3.15% | $370.04M | 7.25 | $1.93B | 43.83 | ||
| ADMA | ADMA BIOLOGICS INC | $9.23 | $7.21 | 28.01% | 12.82x | 11.60x | 4.11x | 5.06x | 0.75x | $116.47M | 5.53% | $408.21M | 1.79 | $2.13B | 9.14 | ||
| TECH | BIO-TECHNE CORP | $72.12 | $16.93 | 325.98% | 61.64x | 34.54x | 9.26x | 5.36x | 1.94x | $263.22M | 2.34% | $2.11B | 13.52 | $11.33B | 32.60 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.01 | $7.86 | 52.71% | 12.64x | 11.04x | 5.22x | 3.28x | 1.10x | $82.01M | 11.54% | $217.65M | 3.68 | $569.37M | 7.36 | ||
| TGTX | TG THERAPEUTICS INC | $53.89 | $23.17 | 132.62% | 17.50x | 54.23x | 9.55x | 13.66x | 1.95x | $17.39M | 0.23% | $604.08M | 4.26 | $8.52B | 61.18 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $245.80 | $183.93 | 33.64% | 16.11x | 9.62x | 3.38x | 3.32x | 0.68x | $1.62B | 10.43% | $4.80B | 75.98 | $18.73B | 11.59 | ||
| EXEL | EXELIXIS INC | $56.12 | $30.96 | 81.26% | 17.06x | 16.99x | 5.78x | 7.54x | 1.12x | $1.17B | 8.33% | $1.84B | 7.35 | $13.79B | 12.68 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $515.44 | $157.25 | 227.78% | 29.74x | 26.81x | 10.39x | 6.45x | 2.11x | $3.80B | 2.90% | $20.25B | 79.81 | $126.48B | 22.98 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $284.47 | $88.80 | 220.34% | 28.25x | 30.11x | 19.64x | 5.86x | 2.13x | $130.62M | 2.29% | $967.52M | 48.22 | $5.80B | 20.77 | ||
| MDXG | MIMEDX GROUP INC | $4.57 | $1.47 | 210.27% | 114.25x | -32.57x | 1.90x | 3.08x | 1.09x | $44.50M | 6.59% | $216.00M | 1.46 | $547.49M | 24.00 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.13 | $6.14 | -81.60% | 8.07x | -3.82x | 1.39x | 1.49x | 0.06x | $19.58M | 29.91% | $44.20M | 0.76 | $17.07M | 2.23 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $41.52 | $31.10 | 33.52% | 13.22x | 9.96x | 2.51x | 2.42x | 0.79x | $354.90M | 14.75% | $999.24M | 17.25 | $2.02B | 7.22 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $781.49 | $440.80 | 77.29% | 18.63x | 14.01x | 5.17x | 2.54x | 0.99x | $3.76B | 4.68% | $31.71B | 308.48 | $80.71B | 14.04 | ||
| UTHR | UNITED THERAPEUTICS CORP | $497.11 | $197.96 | 151.11% | 16.44x | 18.56x | 6.71x | 3.33x | 2.84x | $1.09B | 5.16% | $6.40B | 150.24 | $19.52B | 11.64 | ||
| INCY | INCYTE CORP | $121.47 | $60.87 | 99.55% | 14.96x | 34.26x | 4.18x | 3.88x | 1.68x | $1.92B | 7.89% | $6.34B | 31.66 | $20.67B | 10.00 | ||
| VCYT | VERACYTE INC | $40.87 | $7.00 | 484.08% | 28.38x | 39.09x | 5.82x | 2.37x | 112.89x | $165.99M | 5.08% | $1.39B | 17.36 | $3.02B | 21.65 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.